BOTANIX PHARMACEUTICALS LTD

7.59%

42.5¢

Market Cap $778.9M

Healthcare Biotechnology

Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix... Botanix (ASX:BOT) is an ASX-listed dermatology company based in Philadelphia and Phoenix (USA), committed to the development of novel treatments for common skin diseases and infections.More

FIREBRICK PHARMA

Invest in the Future of Healthcare – Firebrick Pharma’s Investor Webinar

Latest Threads

Tag

Subject

BOT

Bot Chart

336 337 338

23/04/25

20K

7.1M

23/04/25

Last post CloseTheMarkets

20K

7.1M

BOT

Ann: Botanix $40 Million Capital Raising for Sofdra Rollout

4 5 6

23/04/25

314

102K

23/04/25

Last post benno54

314

102K

BOT

Short Tracker

23/04/25

15K

23/04/25

Last post marsman86

15K

BOT

BOT - Anything but charting

238 239 240

23/04/25

14K

5.5M

23/04/25

Last post MrMikiKing

14K

5.5M

BOT

Current And Future Valuation 2025

2 3

23/04/25

123

50K

23/04/25

Last post iamagenius

123

50K

BOT Biotech

Broker Data - BOT

2 3

22/04/25

127

51K

22/04/25

Last post DimDim

127

51K

BOT

Reviews

2 3

21/04/25

156

63K

21/04/25

Last post Mikey74

156

63K

BOT

Botanix Sales

16/04/25

1.7K

16/04/25

Last post dachopper

1.7K

See All Discussions

Timeline

Botanix Webinar - 15 April 2025 - Registration Information
15 Apr 09:55	Share

Proposed issue of securities - BOT
15 Apr 09:51	Share

Botanix $40 Million Capital Raising for Sofdra Rollout
15 Apr 09:50	Share

Trading Halt
14 Apr 09:39	Share

Notification regarding unquoted securities - BOT
02 Apr 19:55	Share

Notification of cessation of securities - BOT
02 Apr 19:55	Share

Change of Director's Interest Notice - D. Sharp
21 Mar 18:37	Share

Notification of cessation of securities - BOT
21 Mar 18:30	Share

Application for quotation of securities - BOT
21 Mar 18:27	Share

Botanix Conference Commercial Update
11 Mar 08:23	Share

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01	Share

Notification regarding unquoted securities - BOT
07 Mar 13:59	Share

Section 708A(5)(e) Notice
28 Feb 09:48	Share

Change of Director's Interest Notice - S. Washer
28 Feb 09:47	Share

Notification of cessation of securities - BOT
28 Feb 09:44	Share

Application for quotation of securities - BOT
28 Feb 09:43	Share

Appendix 4D and Half Year Report
26 Feb 08:13	Share

December 2024 Quarterly Activities Report and Appendix 4C
31 Jan 09:32	Share

Change of Director's Interest Notice - V. Ippolito
17 Jan 12:08	Share

Change in substantial holding from IFL
15 Jan 09:14	Share

Change of Director's Interest Notice - V. Ippolito
09 Jan 18:28	Share

Application for quotation of securities - BOT
09 Jan 18:15	Share

Notification regarding unquoted securities - BOT
09 Jan 18:12	Share

Ceasing to be a substantial holder
09 Jan 17:56	Share

First Sofdra Prescriptions as Commercialisation Ramps Up
17 Dec 08:18	Share

Change of Director's Interest Notice x 5
03 Dec 20:19	Share

Section 708A(5)(e) Notice
02 Dec 20:21	Share

Notification regarding unquoted securities - BOT
02 Dec 20:19	Share

Application for quotation of securities - BOT
02 Dec 20:16	Share

Botanix Presentation at Bell Potter Healthcare Conference
19 Nov 11:15	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 42.5¢		Change 0.030(7.59%)		Mkt cap ! $778.9M

Open	High	Low	Value	Volume
40.5¢	43.0¢	40.5¢	$2.925M	6.938M

Buyers (Bids)

No.	Vol.	Price($)
6	181950	42.0¢

Sellers (Offers)

Price($)	Vol.	No.
42.5¢	265043	2

View Market Depth

No.	Vol.	Price($)
5	179950	0.420
4	73257	0.415
7	119444	0.410
1	55896	0.405
6	85001	0.400

Price($)	Vol.	No.
0.425	265043	2
0.430	257436	7
0.435	199764	5
0.440	170605	5
0.445	3847	1

Last trade - 16.10pm 23/04/2025 (20 minute delay)

BOT (ASX) Chart

BOTANIX PHARMACEUTICALS LTD

Latest Threads

More Strong Drilling Results for Apollo Hill Gold Project

Timeline

Featured News

Latest Articles

First Sofdra prescriptions for excessive sweating condition pushes Botanix towards full commercial launch

Botanix has reported the first prescriptions of its drug Sofdra (sofpironium) to treat hyperhidrosis, a condition of excessive sweating.

US FDA approves Botanix Pharma's excessive underarm sweat drug

Botanix on Thursday described itself as having transitioned from a development stage to being revenue-generating dermatology company.

Botanix isn't sweating on FDA approval for Sofdra

Botanix has submitted the last label materials to the FDA seeking approval for Sofdra™ a prescription treatment for underarm sweating.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News